Evidence map›Paper›PMID 33800000›Full record

ReviewBiomolecules2021

Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.

Md Tanvir Kabir, Md Habibur Rahman, Rokeya Akter, Tapan Behl, Deepak Kaushik, Vineet Mittal, Parijat Pandey, Muhammad Furqan Akhtar, Ammara Saleem, Ghadeer M Albadrani and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 1 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 1 synthesis or guideline pooled it, 200 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 13 institutions in 7 countries.

Md Tanvir KabirDepartment of Pharmacy, Brac University, 66 Mohakhali, Dhaka 1212, Bangladesh.ORCID 0000-0002-6078-8587
Md Habibur RahmanDepartment of Pharmacy, Southeast University, Banani, Dhaka 1213, Bangladesh.ORCID 0000-0001-6099-5693
Rokeya AkterDepartment of Pharmacy, Jagannath University, Sadarghat, Dhaka 1100, Bangladesh.
Tapan BehlChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Deepak KaushikDepartment of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak 124001, India.ORCID 0000-0002-3286-196X
Vineet MittalDepartment of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak 124001, India.ORCID 0000-0002-0980-5628
Parijat PandeyShri Baba Mastnath Institute of Pharmaceutical Sciences and Research, Baba Mastnath University, Rohtak 124001, India.ORCID 0000-0003-2298-3645
Muhammad Furqan AkhtarRiphah Institute of Pharmaceutical Sciences, Lahore Campus, Riphah International University, Lahore 54000, Pakistan.ORCID 0000-0002-2407-1503
Ammara SaleemDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan.ORCID 0000-0002-2478-7800
Ghadeer M AlbadraniDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11474, Saudi Arabia.
Mohamed KamelDepartment of Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.
Shaden A M KhalifaDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, S-10691 Stockholm, Sweden.
Hesham R El-SeediPharmacognosy Group, Department of Medicinal Chemistry, Uppsala University, Biomedical Centre, Box 574, 751 23 Uppsala, Sweden.
Mohamed M Abdel-DaimPharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt.ORCID 0000-0002-4341-2713
Maharshi Dayanand University · INBaba Mastnath University · INBRAC University · BDCairo University · EGChitkara University · INGovernment College University, Faisalabad · PKJagannath University · BDJiangsu University · CNPrincess Nourah bint Abdulrahman University · SARiphah International University · PKSoutheast University · BDStockholm University · SESuez Canal University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a major burden of disease globally. Each year, tens of millions of people are diagnosed with cancer worldwide, and more than half of the patients eventually die from it. Significant advances have been noticed in cancer treatment, but the mortality and incidence rates of cancers are still high. Thus, there is a growing research interest in developing more effective and less toxic cancer treatment approaches. Curcumin (CUR), the major active component of turmeric (

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorCurcumaCurcuminCyclooxygenase 1Drug Delivery SystemsHumansNF-kappa BPlant ExtractsSignal TransductionSTAT3 Transcription FactorTRPP Cation ChannelsAntineoplastic AgentsCurcuminCyclooxygenase 1NF-kappa BPlant ExtractsSTAT3 Transcription FactorTRPP Cation Channelsturmeric extractanticancercellular mechanismsCurcuma longacurcuminmechanism of actionnanoformulations

Identifiers

PMID33800000
PMCPMC8001478
OpenAlexW3134935696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.